Annals of Colorectal Research

Published by: Kowsar

New Insights into the Roles of Yes-Associated Protein (YAP1) in Colorectal Cancer Development and Progression

Fariba Dehghanian 1 , Zahra Azhir 1 , Atefeh Akbari 2 and Zohreh Hojati 1 , *
Authors Information
1 Division of Genetics, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran
2 Division of Biochemistry, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran
Article information
  • Annals of Colorectal Research: June 30, 2019, 7 (2); e96458
  • Published Online: August 24, 2019
  • Article Type: Review Article
  • Received: July 18, 2019
  • Accepted: August 4, 2019
  • DOI: 10.5812/acr.96458

How to Cite: Dehghanian F, Azhir Z, Akbari A, Hojati Z. New Insights into the Roles of Yes-Associated Protein (YAP1) in Colorectal Cancer Development and Progression, Ann Colorectal Res. 2019 ; 7(2):e96458. doi: 10.5812/acr.96458.

Copyright © 2019, Annals of Colorectal Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Molecular Structures of Hippo Pathway
3. The Regulation of YAP1 and Crosstalk of YAP1 with Other Pathways in CRC Progression
4. Non-Coding RNAs
5. MiRNAs and YAP1 in CRC Development
6. LncRNAs and YAP1 in CRC
7. CircRNAs and YAP1 in CRC
8. Conclusions
  • 1. Marmol I, Sanchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18(1). doi: 10.3390/ijms18010197. [PubMed: 28106826]. [PubMed Central: PMC5297828].
  • 2. Motovali-Bashi M, Hojati Z, Hajihoseiny S, Hemmati S. The stromelysin-1 5A/5A genotype enhances colorectal cancer cell invasion in Iranian population. J Res Med Sci. 2012;17(10):962-6. [PubMed: 23825998]. [PubMed Central: PMC3698657].
  • 3. Pan Y, Tong JHM, Lung RWM, Kang W, Kwan JSH, Chak WP, et al. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer. Mol Cancer. 2018;17(1):102. doi: 10.1186/s12943-018-0853-6. [PubMed: 30037330]. [PubMed Central: PMC6057036].
  • 4. Zhou Z, Zhang HS, Zhang ZG, Sun HL, Liu HY, Gou XM, et al. Loss of HACE1 promotes colorectal cancer cell migration via upregulation of YAP1. J Cell Physiol. 2019;234(6):9663-72. doi: 10.1002/jcp.27653. [PubMed: 30362561].
  • 5. Dehghanian F, Hojati Z, Esmaeili F, Masoudi-Nejad A. Network-based expression analyses and experimental validations revealed high co-expression between Yap1 and stem cell markers compared to differentiated cells. Genomics. 2019;111(4):831-9. doi: 10.1016/j.ygeno.2018.05.007. [PubMed: 29775782].
  • 6. Ou C, Sun Z, Li S, Li G, Li X, Ma J. Dual roles of yes-associated protein (YAP) in colorectal cancer. Oncotarget. 2017;8(43):75727-41. doi: 10.18632/oncotarget.20155. [PubMed: 29088905]. [PubMed Central: PMC5650460].
  • 7. Dehghanian F, Hojati Z, Hosseinkhan N, Mousavian Z, Masoudi-Nejad A. Reconstruction of the genome-scale co-expression network for the Hippo signaling pathway in colorectal cancer. Comput Biol Med. 2018;99:76-84. doi: 10.1016/j.compbiomed.2018.05.023. [PubMed: 29890510].
  • 8. Azad T, Janse van Rensburg HJ, Lightbody ED, Neveu B, Champagne A, Ghaffari A, et al. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun. 2018;9(1):1061. doi: 10.1038/s41467-018-03278-w. [PubMed: 29535383]. [PubMed Central: PMC5849716].
  • 9. Zhang M, Zhao Y, Zhang Y, Wang D, Gu S, Feng W, et al. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5 Pt A):1770-82. doi: 10.1016/j.bbadis.2018.03.005. [PubMed: 29510195].
  • 10. Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis. Cancer Lett. 2017;385:215-24. doi: 10.1016/j.canlet.2016.10.020. [PubMed: 27773750].
  • 11. Xiao Y, Hill MC, Zhang M, Martin TJ, Morikawa Y, Wang S, et al. Hippo signaling plays an essential role in cell state transitions during cardiac fibroblast development. Dev Cell. 2018;45(2):153-169 e6. doi: 10.1016/j.devcel.2018.03.019. [PubMed: 29689192]. [PubMed Central: PMC5947860].
  • 12. Warren JSA, Xiao Y, Lamar JM. YAP/TAZ activation as a target for treating metastatic cancer. Cancers (Basel). 2018;10(4). doi: 10.3390/cancers10040115. [PubMed: 29642615]. [PubMed Central: PMC5923370].
  • 13. Tang JY, Yu CY, Bao YJ, Chen L, Chen J, Yang SL, et al. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1. Cell Cycle. 2018;17(1):102-9. doi: 10.1080/15384101.2017.1403687. [PubMed: 29157094]. [PubMed Central: PMC5815434].
  • 14. Wang X, Freire Valls A, Schermann G, Shen Y, Moya IM, Castro L, et al. YAP/TAZ orchestrate VEGF signaling during developmental angiogenesis. Dev Cell. 2017;42(5):462-478 e7. doi: 10.1016/j.devcel.2017.08.002. [PubMed: 28867486].
  • 15. Ou C, Sun Z, Li X, Li X, Ren W, Qin Z, et al. MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. Cancer Lett. 2017;399:53-63. doi: 10.1016/j.canlet.2017.04.011. [PubMed: 28433598].
  • 16. Yang R, Cai TT, Wu XJ, Liu YN, He J, Zhang XS, et al. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer. Immunology. 2018;155(2):263-72. doi: 10.1111/imm.12949. [PubMed: 29770434]. [PubMed Central: PMC6142285].
  • 17. Greenhough A, Bagley C, Heesom KJ, Gurevich DB, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10(11). doi: 10.15252/emmm.201708699. [PubMed: 30143543]. [PubMed Central: PMC6220329].
  • 18. Li H, He F, Zhao X, Zhang Y, Chu X, Hua C, et al. YAP inhibits the apoptosis and migration of human rectal cancer cells via suppression of JNK-Drp1-mitochondrial fission-HtrA2/Omi pathways. Cell Physiol Biochem. 2017;44(5):2073-89. doi: 10.1159/000485946. [PubMed: 29241219].
  • 19. Ferreira HJ, Esteller M. Non-coding RNAs, epigenetics, and cancer: Tying it all together. Cancer Metastasis Rev. 2018;37(1):55-73. doi: 10.1007/s10555-017-9715-8. [PubMed: 29374363].
  • 20. Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5-18. doi: 10.1038/nrc.2017.99. [PubMed: 29170536]. [PubMed Central: PMC6337726].
  • 21. Choe MH, Yoon Y, Kim J, Hwang SG, Han YH, Kim JS. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP. Cell Death Dis. 2018;9(6):640. doi: 10.1038/s41419-018-0698-3. [PubMed: 29844307]. [PubMed Central: PMC5974323].
  • 22. Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15(6):321-33. doi: 10.1038/nrc3932. [PubMed: 25998712]. [PubMed Central: PMC4859809].
  • 23. Moridikia A, Mirzaei H, Sahebkar A, Salimian J. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol. 2018;233(2):901-13. doi: 10.1002/jcp.25801. [PubMed: 28092102].
  • 24. Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, et al. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer. PLoS One. 2014;9(6). e96767. doi: 10.1371/journal.pone.0096767. [PubMed: 24892549]. [PubMed Central: PMC4043686].
  • 25. Xu L, Li M, Wang M, Yan D, Feng G, An G. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. BMC Cancer. 2014;14:714. doi: 10.1186/1471-2407-14-714. [PubMed: 25255814]. [PubMed Central: PMC4181388].
  • 26. Hwang HW, Wentzel EA, Mendell JT. Cell-cell contact globally activates microRNA biogenesis. Proc Natl Acad Sci U S A. 2009;106(17):7016-21. doi: 10.1073/pnas.0811523106. [PubMed: 19359480]. [PubMed Central: PMC2678439].
  • 27. Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD, et al. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156(5):893-906. doi: 10.1016/j.cell.2013.12.043. [PubMed: 24581491]. [PubMed Central: PMC3982296].
  • 28. Sun M, Song H, Wang S, Zhang C, Zheng L, Chen F, et al. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer. J Hematol Oncol. 2017;10(1):79. doi: 10.1186/s13045-017-0445-8. [PubMed: 28356122]. [PubMed Central: PMC5372308].
  • 29. Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S, et al. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2019;38(14):2627-44. doi: 10.1038/s41388-018-0628-y. [PubMed: 30531836]. [PubMed Central: PMC6484768].
  • 30. Fesler A, Liu H, Ju J. Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1. Oncotarget. 2018;9(2):2367-83. doi: 10.18632/oncotarget.23414. [PubMed: 29416778]. [PubMed Central: PMC5788646].
  • 31. Hauptman N, Glavac D. Long non-coding RNA in cancer. Int J Mol Sci. 2013;14(3):4655-69. doi: 10.3390/ijms14034655. [PubMed: 23443164]. [PubMed Central: PMC3634483].
  • 32. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339-46. doi: 10.1038/nature10887. [PubMed: 22337053]. [PubMed Central: PMC4197003].
  • 33. Xie X, Tang B, Xiao YF, Xie R, Li BS, Dong H, et al. Long non-coding RNAs in colorectal cancer. Oncotarget. 2016;7(5):5226-39. doi: 10.18632/oncotarget.6446. [PubMed: 26637808]. [PubMed Central: PMC4868682].
  • 34. Zhong X, Lu M, Wan J, Zhou T, Qin B. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression. Biomed Pharmacother. 2018;107:382-9. doi: 10.1016/j.biopha.2018.07.118. [PubMed: 30099342].
  • 35. Ding HX, Lv Z, Yuan Y, Xu Q. The expression of circRNAs as a promising biomarker in the diagnosis and prognosis of human cancers: A systematic review and meta-analysis. Oncotarget. 2018;9(14):11824-36. doi: 10.18632/oncotarget.23484. [PubMed: 29545939]. [PubMed Central: PMC5837763].
  • 36. Hsiao KY, Lin YC, Gupta SK, Chang N, Yen L, Sun HS, et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 2017;77(9):2339-50. doi: 10.1158/0008-5472.CAN-16-1883. [PubMed: 28249903]. [PubMed Central: PMC5910173].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments